熱門資訊> 正文

GH Research定价1.175亿美元的股票发行

2026-04-29 20:41

COMPASS Pathways Plc Sponsored ADR(CMPS) 0

GH Research said on Wednesday it priced an underwritten U.S. offering of 6.53M ordinary shares at $18 each, for gross proceeds of about $117.5M
The company is selling all of the shares in the offering, which is expected to close on April 30.
The transaction was initiated by Lynx1 Capital Management, with participation from Deep Track Capital and Foresite Capital.
Stifel, Cantor Fitzgerald and RBC Capital Markets are acting as joint book-running managers. Canaccord Genuity and Citizens Capital Markets are co-lead managers.
Shares down -1% premarket.

More on GH Research

GH Research: WH Decision On Psychedelics To Treat Depression Makes Bull Case
GH Research FY25 Results: Strong Cash Position As GH001 Advances Toward Phase 3
Cybin stands out as the most undervalued psychedelic stock as Trump signs on faster PTSD research
Psychedelic stocks rally after Trump orders faster PTSD research; Compass Pathways, Atai lead gains
Seeking Alpha’s Quant Rating on GH Research

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。